Safety, Tolerability and Pharmacokinetics of SHP465 in Children Aged 4 to 5 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)
Clinical trial NCT03327402 · COMPLETED
Trial details
- NCT number
- NCT03327402
- Sponsor
- Shire
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-13
- Primary completion
- 2018-10-05
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.